Showing 1-15 of 34 results
Health Lab
A large grant for Michigan Medicine will launch important research to improve the screening and treatment for a gynecologic disorder that disproportionately impacts Black and Hispanic populations
Health Lab
A weight navigation program for primary care patients with obesity led to more use of proven weight management strategies and more weight loss
Health Lab
A national study from Michigan Medicine shows that the use of these weight loss drugs is increasing rapidly in adolescents and young adults 12-25 years, especially females.
Health Lab
Experts in brain cancer outline current discoveries and offer a path of hope for glioblastoma treatment
Health Lab Podcast
A survey focused on how much people in their teens and early 20s know about periods and their experience and attitudes around “period poverty”.
Health Lab
Survey shows many teens and young adults support making menstrual products more accessible to fight "period poverty."
Health Lab
At-home test can detect tumor DNA fragments in urine samples, providing a non-invasive alternative to traditional blood-based biomarker tests
Health Lab
Many women don’t get cervical cancer screening such as Pap tests, or don’t go for follow up diagnostic tests; a new study shows what could happen if all of them did.
Health Lab
Patients can now enroll in a clinical trial to test a groundbreaking nonsurgical treatment for cervical lesions that affect nearly 300,000 women in the United States every year.
News Release
Lung disease specialist comes to Michigan from Vanderbilt University School of Medicine to lead largest department
Health Lab
Using a chip to process blood samples, doctors can monitor the amount of cancer cells in a patient’s blood to determine how well a treatment is working by the fourth week, according to a new study.
Health Lab
Elective surgery study shows older adults have concerns about what it will cost them, how much work they’ll miss and whether they’ll catch COVID-19.
Health Lab
Research from Michigan Medicine experts is shedding light and potentially expanding options for patients living with an aggressive childhood cancer.
Health Lab
Recently approved by the Food and Drug Administration, Pluvicto is a radionuclide-labelled drug administered to patients showing promising results.